Methods and compositions for treating Degos' disease

Details for Australian Patent Application No. 2011223866 (hide)

Owner Alexion Pharmaceuticals Inc.

Inventors Magro, Cynthia

Agent Shelston IP

Pub. Number AU-A-2011223866

PCT Pub. Number WO2011/109338

Priority 61/309,393 01.03.10 US

Filing date 1 March 2011

Wipo publication date 9 September 2011

International Classifications

C07K 16/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61P 7/00 Drugs for disorders of the blood or the extracellular fluid

A61P 37/02 Drugs for immunological or allergic disorders

Event Publications

27 September 2012 PCT application entered the National Phase

  PCT publication WO2011/109338 Priority application(s): WO2011/109338

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011223873-Isotopically enriched arylsulfonamide CCR3 antagonists

2011223861-6 -benzylphenyl2 - sulfurterahydropyran-3, 4, 5 -triol derivatives as inhibitors of sodium -glucose cotrans porters 1 and 2 for use in diabetic patients